Netskope (NASDAQ: NTSK - Get Free Report) and Doximity (NYSE: DOCS - Get Free Report) are both mid-cap services companies, but which is the better stock? We will compare the two companies based on the
DOCS beats Q3 EPS and revenue estimates, but shares plunge 38.5% after hours as margins contract and FY26 revenue guidance is lowered.

Why Doximity Stock Plummeted Today

11:43am, Friday, 06'th Feb 2026
Doximity's sales growth slowed to 10% in Q3, and its net income dipped. Worse yet, the company guided for sales growth of only 4% in the upcoming quarter.
Major stock indexes opened higher Friday, a day after equities sank amid risk-off sentiment. Still, the Nasdaq and S&P 500 were poised to register sharp weekly losses.

Breakfast News: Amazon's AWS Special Delivery

07:30am, Friday, 06'th Feb 2026
Costly plans push Amazon down, Bitcoin falls in crypto slump, and more
Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Doximity (DOCS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compa
Doximity (DOCS) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.45 per share a year ago.
Doximity, which operates an online networking service for medical professionals, reported third-quarter revenue of $185.05 million, beating estimates of $182.20 million, according to Benzinga Pro. Rev
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named the #1 Telehealth Video Co
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 20
Doximity (NYSE: DOCS - Get Free Report) and Aether (NASDAQ: ATHR - Get Free Report) are both services companies, but which is the superior stock? We will compare the two businesses based on the streng
Evaluate the expected performance of Doximity (DOCS) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metric
AI momentum is reshaping med-tech, with Tempus AI scaling diagnostics and Doximity leveraging platform-wide AI, strong margins, and cash flow to gain an edge.
Navan (NASDAQ: NAVN - Get Free Report) and Doximity (NYSE: DOCS - Get Free Report) are both mid-cap services companies, but which is the superior business? We will contrast the two companies based on
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE